Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast-tissue sampling for risk assessment and prevention.

C J Fabian1, B F Kimler, M S Mayo

  • 1Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KA 66160, USA. cfabian@kumc.edu

Endocrine-Related Cancer
|June 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remote delivery of a weight management intervention for adults with intellectual disabilities: Results from a randomized non-inferiority trial.

Disability and health journal·2024
Same author

Tuberculosis in a Boar.

The Journal of comparative medicine and veterinary archives·2022
Same author

Weight management for adolescents with intellectual and developmental disabilities: Rationale and design for an 18month randomized trial.

Contemporary clinical trials·2016
Same author

A virtual reality intervention (Second Life) to improve weight maintenance: Rationale and design for an 18-month randomized trial.

Contemporary clinical trials·2015
Same author

Weight management for individuals with intellectual and developmental disabilities: rationale and design for an 18 month randomized trial.

Contemporary clinical trials·2013
Same author

Is symptom relief associated with reduction in gastric retention after gastric electrical stimulation treatment in patients with gastroparesis? A sensitivity analysis with logistic regression models.

Neurogastroenterology and motility·2012

Breast tissue and duct fluid analysis offers key biomarkers for breast cancer risk assessment and prevention. Methods like nipple-aspirate fluid and fine-needle aspiration help identify atypical cells, indicating increased cancer risk.

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Preventive Medicine

Background:

  • Breast tissue and duct fluid are valuable sources for breast cancer risk assessment and evaluating prevention interventions.
  • Current methods for sampling breast tissue in asymptomatic women include nipple-aspirate fluid (NAF), random periareolar fine-needle aspiration (RPFNA), and ductal lavage.
  • Atypical cells found in NAF or RPFNA specimens are linked to a higher breast cancer risk and can further stratify risk using the Gail model.

Purpose of the Study:

  • To review methods for sampling breast tissue and duct fluid for breast cancer risk assessment and prevention intervention response.
  • To evaluate the utility of various biomarkers, including atypical cells and non-genetic markers, in breast cancer risk stratification.
  • To discuss the strengths and weaknesses of different sampling techniques used in breast cancer research.

Related Experiment Videos

Main Methods:

  • Analysis of nipple-aspirate fluid (NAF) and random periareolar fine-needle aspiration (RPFNA) for atypical cells.
  • Utilizing ductal lavage for risk prediction and assessing breast intra-epithelial neoplasia.
  • Reviewing established non-genetic biomarkers such as mammographic breast density and serum hormone levels.

Main Results:

  • Prospective trials indicate that atypical cells in NAF and RPFNA are associated with increased breast cancer risk.
  • RPFNA-detected atypia can further stratify risk within the Gail risk-assessment model.
  • Ongoing trials are evaluating risk prediction using ductal lavage fluid and assessing the role of non-genetic biomarkers.

Conclusions:

  • Breast fluid and tissue sampling methods provide crucial data for breast cancer risk assessment and prevention.
  • Atypical cell detection via NAF and RPFNA is a significant indicator of elevated breast cancer risk.
  • Further research is ongoing to define the role of various biomarkers and refine sampling techniques for comprehensive risk evaluation and intervention assessment.